Meta-Analysis
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8831-8843
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8831
Figure 1
Figure 1 Flow diagram: Search results.
Figure 2
Figure 2 Forest plot representing the pooled and individual annual incidence rate for malignant (high grade dysplasia and/or esophageal adenocarcinoma) transformation in confirmed low grade dysplasia patients.
Figure 3
Figure 3 Funnel plot assessing for publication bias (annual incidence rate for malignant transformation in confirmed low grade dysplasia patients).
Figure 4
Figure 4 Forest plot representing the pooled and individual annual incidence rate for esophageal adenocarcinoma transformation in confirmed high grade dysplasia patients.
Figure 5
Figure 5 Forest plot representing the pooled and individual annual incidence rate for malignant (high grade dysplasia and/or esophageal adenocarcinoma) transformation in confirmed No dysplasia in Barrett’s esophagus patients.
Figure 6
Figure 6 Funnel plot assessing for publication bias (annual incidence rate for malignant transformation in confirmed No dysplasia in Barrett’s esophagus patients).
Figure 7
Figure 7 Forest plot representing the pooled and individual annual incidence rate for malignant (high grade dysplasia and/or esophageal adenocarcinoma) transformation in confirmed Indefinite for dysplasia in Barrett’s esophagus patients.
Figure 8
Figure 8 Forest plot representing the pooled and individual annual incidence rate for malignant (high grade dysplasia and/or esophageal adenocarcinoma) transformation in confirmed low grade dysplasia patients - Only prospective studies.